Balyasny Asset Management LLC Exact Sciences Corp Transaction History

Balyasny Asset Management LLC

  • $63.6 Billion
  • Q4 2024

A detailed history of Balyasny Asset Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Balyasny Asset Management LLC holds 4,900 shares of EXAS stock, worth $212,121. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,900
Previous 12,300 60.16%
Holding current value
$212,121
Previous $837,000 67.14%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$49.33 - $71.97 $29.3 Million - $42.7 Million
593,319 New
593,319 $33.3 Million
Q2 2024

Aug 14, 2024
SELL
$41.33 - $74.26 $18 Million - $32.3 Million
-435,177 Reduced 57.2%
325,668 $13.8 Million
Q1 2024

May 13, 2024
BUY
$56.27 - $73.77 $42.4 Million - $55.6 Million
754,323 Added 11565.82%
760,845 $52.5 Million
Q4 2023

Feb 14, 2024
SELL
$59.06 - $75.72 $48,488 - $62,166
-821 Reduced 11.18%
6,522 $482,000
Q3 2023

Nov 14, 2023
SELL
$65.94 - $99.04 $14.9 Million - $22.3 Million
-225,587 Reduced 96.85%
7,343 $500,000
Q2 2023

Aug 14, 2023
BUY
$62.68 - $95.05 $9.27 Million - $14.1 Million
147,954 Added 174.11%
232,930 $21.9 Million
Q1 2023

May 15, 2023
SELL
$47.19 - $70.77 $51 Million - $76.5 Million
-1,081,433 Reduced 92.71%
84,976 $5.76 Million
Q4 2022

Feb 14, 2023
BUY
$30.35 - $53.15 $35.4 Million - $62 Million
1,166,409 New
1,166,409 $57.7 Million
Q2 2022

Aug 15, 2022
BUY
$35.61 - $76.23 $958,656 - $2.05 Million
26,921 Added 463.44%
32,730 $1.29 Million
Q3 2021

Nov 15, 2021
BUY
$90.24 - $124.05 $524,204 - $720,606
5,809 New
5,809 $554,000
Q2 2021

Aug 16, 2021
SELL
$93.66 - $139.27 $24.1 Million - $35.8 Million
-257,195 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$116.57 - $155.01 $30 Million - $39.9 Million
257,195 New
257,195 $33.9 Million
Q3 2020

Nov 16, 2020
SELL
$72.92 - $102.01 $2.75 Million - $3.84 Million
-37,687 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$55.75 - $92.75 $2.1 Million - $3.5 Million
37,687 New
37,687 $3.28 Million
Q2 2018

Aug 14, 2018
SELL
$37.84 - $69.96 $394,557 - $729,472
-10,427 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$39.82 - $57.53 $50,690 - $73,235
-1,273 Reduced 10.88%
10,427 $421,000
Q4 2017

Feb 14, 2018
SELL
$46.49 - $60.51 $125,523 - $163,377
-2,700 Reduced 18.75%
11,700 $615,000
Q3 2017

Nov 14, 2017
BUY
$37.05 - $47.12 $533,520 - $678,528
14,400
14,400 $679,000

Others Institutions Holding EXAS

# of Institutions
669
Shares Held
152M
Call Options Held
4.25M
Put Options Held
1.89M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.66B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email